Skip to content
Clinical Trials – home

Osteomyelitis acute Diagnostics

1 / 1 trials open to patients1 country

In short

Acute osteomyelitis is a serious bone infection that requires prompt medical attention. Understanding when to seek diagnostic testing and what these tests involve can help ensure early detection and treatment, potentially preventing long-term complications like permanent bone damage.

Key points

  • Early diagnostic testing is crucial because acute osteomyelitis treated within 3 to 5 days often clears up completely, but delays can cause permanent bone damage
  • X-rays may look normal in early infection since bone damage doesn't show up for several weeks, making MRI the preferred imaging test for suspected osteomyelitis
  • Bone biopsy remains the gold standard for diagnosis because it identifies the specific organism causing infection, which is essential for choosing the right antibiotic
  • Children with osteomyelitis may not develop fever but instead show subtle signs like refusing to use a limb or unusual irritability
  • People with diabetes, recent surgery, open wounds, or weakened immune systems should seek testing immediately if they develop bone pain and fever
  • No single test can definitively diagnose osteomyelitis—doctors combine physical examination, blood tests, imaging, and cultures to establish the diagnosis
  • Blood cultures can identify bacteria in the bloodstream, but bone cultures are more reliable for determining exactly what organism is infecting the bone
  • MRI is both as sensitive and more specific than bone scans for detecting osteomyelitis, making it the imaging method of choice when available

Introduction: Who Should Seek Diagnostic Testing

If you experience persistent bone pain, fever that lasts several days without a clear cause, or swelling and warmth over a bone area, you should seek medical evaluation for possible osteomyelitis. This is especially important if you've recently had surgery, experienced a bone fracture, or have an open wound that might allow bacteria to reach your bones.

Certain groups of people should be particularly vigilant about seeking diagnostic testing. If you're younger than 20 or older than 50, you face a higher risk of developing bone infections. People with diabetes (a condition where blood sugar levels are too high), especially those with foot ulcers, need to watch carefully for signs of infection. Similarly, if you take medications that weaken your immune system, have recently undergone joint replacement surgery, or have conditions like sickle cell anemia, you should seek testing at the first sign of potential bone infection.

Children deserve special attention when it comes to bone infection symptoms. Young children may not always develop a high fever with osteomyelitis. Instead, they might simply refuse to use an arm or leg and seem unusually irritable. Parents should take their child to a healthcare provider if they notice these signs, as acute osteomyelitis in children typically develops in the long bones of the arms or legs and can progress quickly.

Classic Diagnostic Methods

When you visit a healthcare provider with symptoms suggesting osteomyelitis, the diagnostic process typically begins with a physical examination. Your provider will feel the area around the affected bone for tenderness, swelling, or warmth. If you have a foot sore, they may use a dull probe to determine how close the sore is to the underlying bone, which helps assess infection risk.

Blood Tests

Blood tests play an important role in diagnosing acute osteomyelitis, though no single blood test can definitively confirm the condition. These tests can show high levels of white blood cells and other markers in the blood that indicate your body is fighting an infection. A type of blood test called a blood culture may also be performed to identify the specific type of bacteria causing the infection, which is crucial for selecting the right antibiotic treatment.

Blood tests help healthcare professionals decide what additional tests and procedures you may need. They provide valuable information about the severity of infection and whether bacteria have spread into your bloodstream, which can occur with acute osteomyelitis.

Imaging Tests

Plain X-rays are usually the first imaging test performed when bone infection is suspected. X-rays can show damage to bone, but there's an important limitation: the damage may not appear on X-rays until osteomyelitis has been present for several weeks. This means that if your infection is more recent, you may need more detailed imaging tests even if the X-ray looks normal.

Magnetic resonance imaging, or MRI, is considered the imaging method of choice for suspected osteomyelitis. Using radio waves and a strong magnetic field, MRI scans create detailed images of bones and the soft tissues around them. This test is particularly valuable because it can detect infection earlier than X-rays and can show areas of bone that have started to die due to infection. MRI is as sensitive as and more specific than other imaging methods for diagnosing bone infections.

A CT scan (computed tomography) combines X-ray images taken from many different angles to provide views of internal body structures. You might have a CT scan if you cannot have an MRI, perhaps because you have a pacemaker or other metal implant that makes MRI unsafe.

A bone scan is a nuclear imaging test that uses small amounts of radioactive substances, called radioactive tracers, along with a special camera and computer. Cells and tissues that are infected absorb the tracer, so the infection shows up on the scan. This test can help identify areas of bone that are affected by infection throughout the body.

Tissue and Bone Sampling

The preferred diagnostic criterion for osteomyelitis is a positive bacterial culture from a bone biopsy, performed when bone tissue death is present. A bone biopsy involves removing a small piece of bone for testing. This procedure can show what type of bacteria, fungus, or other microorganism has infected your bone. Knowing the specific type of organism helps your healthcare professional choose an antibiotic that works well for that particular infection.

Sometimes doctors take a tissue biopsy, where a small sample of tissue near the infected bone is removed for examination. Wound swabs may also be taken if there is drainage from a wound near the affected bone, though cultures from bone itself are more reliable for identifying the exact organism causing infection.

The diagnosis of acute osteomyelitis can be established based on several specific findings: pus found during needle aspiration of the bone, positive bacterial culture from bone or blood, presence of classic signs and symptoms of acute osteomyelitis, and radiographic changes typical of the infection.

Establishing the Diagnosis

Osteomyelitis is usually diagnosed clinically with support from imaging and laboratory findings. Your healthcare provider combines information from your symptoms, physical examination, blood tests, imaging results, and when available, cultures from bone or tissue samples. This comprehensive approach helps distinguish osteomyelitis from other conditions that might cause similar symptoms, such as bone tumors, fractures that haven't healed properly, or soft tissue infections that haven't spread to bone.

Acute osteomyelitis typically presents within several days to one week after symptom onset. Patients usually have signs of systemic illness, including fever, irritability, and lethargy, along with local signs like tenderness over the involved bone and decreased range of motion in adjacent joints. The combination of these clinical features with laboratory and imaging findings helps establish the diagnosis.

Diagnostics for Clinical Trial Qualification

While the sources provided do not contain specific information about diagnostic criteria or testing protocols used for enrolling patients with acute osteomyelitis in clinical trials, the standard diagnostic methods described above would typically be required to confirm the diagnosis before trial participation. These would include positive bone cultures to identify the causative organism, imaging studies to determine the extent of bone involvement, and blood tests to assess the severity of infection and overall health status.

Did you know?

  1. Bone infections are so ancient that archaeologists have found evidence of osteomyelitis in animal fossils, making it one of the oldest diseases known to affect living creatures.
  2. The term "osteomyelitis" wasn't coined until 1844 by a physician named Nelaton, even though the disease had been recognized for centuries under various other names.
  3. Before antibiotics became available in the 1940s, osteomyelitis had such high mortality rates from sepsis that treatment consisted mainly of extensive surgery to remove infected bone, leaving large wounds to heal on their own.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Osteomyelitis acute

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Osteomyelitis+1

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Assistance Publique Hopitaux De Paris
See all 1 trials →filters applied: condition = Osteomyelitis acute

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).